Skip to main content
Log in

Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Humanin (HN) has been reported to be an endogenous peptide that exerts highly selective neuroprotection against cell death induced by various types of Alzheimer's disease-related insults. We previously proposed the much broader cytoprotective potential of HN from the result that HN suppressed serum-deprivation-induced death of rat pheochromocytoma cells. In this study, we showed that HN also suppressed death of human lymphocytes cultured under serum-deprived condition. Further, we revealed, by assaying metabolic activity and survival rate, that HN was a potent factor capable of increasing the metabolic activity of individual serum-deprived lymphocytes. To our knowledge, there is no report described about a rescue factor that increases the metabolic activity of individual serum-deprived cells and prolongs their survival. This novel feature of HN may enable us to apply this peptide for the management of diseases involving poor metabolic activity, such as mitochondria-related disorders and brain ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Selkoe DJ: Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Review. Trends Neurosci 16: 403-409, 1993

    Google Scholar 

  2. Ashall F, Goate AM: Role of the beta-amyloid precursor protein in Alzheimer's disease. Review. Trends Biochem Sci 19: 42-46, 1994

    Google Scholar 

  3. Checler F: Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. Review. J Neurochem 65: 1431-1444, 1995

    Google Scholar 

  4. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 21: 704-706, 1991

    Google Scholar 

  5. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995

    Google Scholar 

  6. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, Schellenberg GD: A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973, 1995

    Google Scholar 

  7. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS: Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Review. Neurology 51: S2-S17; discussion S65–S67, 1998

    Google Scholar 

  8. Fassbender K, Masters C, Beyreuther K: Alzheimer's disease: Molecular concepts and therapeutic targets. Review. Naturwissenschaften 88: 261-267, 2001

    Google Scholar 

  9. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I: A novel rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA 98: 6336-6341, 2001

    Google Scholar 

  10. Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, Abe Y, Kita Y, Nishimoto I: Detailed characterization of neuroprotection by a rescue factor Humanin against various Alzheimer's disease-relevant insults. J Neurosci 21: 9235-9245, 2001

    Google Scholar 

  11. Hashimoto Y, Ito Y, Niikura T, Shao Z, Hata M, Oyama F, Nishimoto I: Mechanisms of neuroprotection by a novel rescue factor Humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun 283: 460-468, 2001

    Google Scholar 

  12. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S: Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 13: 903-907, 2002

    Google Scholar 

  13. Alnemri ES: Hidden powers of the mitochondria. Nature Cell Biol 43: 465-475, 1999

    Google Scholar 

  14. Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303: 474-482, 1993

    Google Scholar 

  15. McElroy WD, DeLuca MA: Firefly and bacterial luminescence: basic science and applications. J Appl Biochem 5: 197-209, 1983

    Google Scholar 

  16. Ebstein RP, Nemanov L, Lubarski G, Dano M, Trevis T, Korczyn AD: Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease. Mol Brain Res 35: 260-268, 1996

    Google Scholar 

  17. Batistatou A, Greene LA: Internucleosomal DNA cleavage and neuronal cell survival/death. J Cell Biol 122: 523-532, 1993

    Google Scholar 

  18. Zhang XJ, Yan J, Cuttle L, Endre Z, Gobe G: Escape from apoptosis after prolonged serum deprivation is associated with the regulation of the mitochondrial death pathway by Bcl-xL. Biochem Biophys Res Commun 277: 487-493, 2000

    Google Scholar 

  19. Atabay C, Cagnoli CM, Kharlamov E, Ikomovic MD, Manev H: Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists. J Neurosci Res 43: 465-475, 1996

    Google Scholar 

  20. Barrientos A, Casademont J, Cardellach F, Estivill X, Urbano-Marquez A, Nunes V: Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Mol Brain Res 52: 284-289, 1997

    Google Scholar 

  21. Tokunaga M, Mita S, Sakuta R, Nonaka I, Araki S: Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol 33: 275-280, 1993

    Google Scholar 

  22. Papa S, Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 174: 305-319, 1997

    Google Scholar 

  23. Rusanen H, Majamaa K, Hassinen IE: Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A → G mutation in mitochondrial DNA. Biochim Biophys Acta 1500: 10-16, 2000

    Google Scholar 

  24. Harris LK, Black RT, Golden KM, Reeves TM, Povlishock JT, Phillips LL: Traumatic brain injury-induced changes in gene expression and functional activity of mitochondrial cytochrome C oxidase. J Neurotrauma 18: 993-1009, 2001

    Google Scholar 

  25. Abel MS, McCandless DW: Elevated gamma-aminobutyric acid levels attenuate the metabolic response to bilateral ischemia. J Neurochem 58: 740-744, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kariya, S., Takahashi, N., Hirano, M. et al. Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes. Mol Cell Biochem 254, 83–89 (2003). https://doi.org/10.1023/A:1027372519726

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027372519726

Navigation